Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now references a newer site revision (v3.6.3) replacing the prior revision (v3.6.0). This looks like a minor platform or UI update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-06-30T01:41:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    New sections provide guidance on reading the study record, common questions, and joining the study, and a recruitment note states that no participants are being recruited. A minor heading formatting change and a new revision label reflect an updated interface.
    Difference
    0.2%
    Check dated 2026-06-15T19:06:18.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, signaling a minor release of the page template. No substantive study content or details appear to be altered.
    Difference
    0.0%
    Check dated 2026-06-08T16:46:45.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.3 to v3.5.4. This is a metadata-level update reflecting a new release version of the page content rather than a change to study information.
    Difference
    0.0%
    Check dated 2026-05-18T12:55:26.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A site interface revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:28.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added three new trial sites: Goztepe Prof.Dr. Suleyman Yalcin City Hospital (Kadiköy, Turkey), The First St.Petersburg State Medical University (Saint Petersburg, Russia), and Scientific Research Institute n.a. N.N. Petrov (Saint Petersburg, Russia); removed New Cross Hospital (Wolverhampton, UK). The total number of locations increased from 165 to 167.
    Difference
    0.3%
    Check dated 2026-04-20T02:48:37.000Z thumbnail image

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.